PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

Tag: olanzapine

Current Issue

Letter to the Editor: Olanzapine-induced Endoplasmic Reticulum Stress Induces Atypical Diabetes and Diabetic Ketoacidosis

Funding/financial disclosures. The author has no conflicts of interest relevant

December 1, 2022 No Comments

Drug Development

Brexpiprazole as a New Serotonin–Dopamine Receptor Modulator: Considering the Clinical Relevance for Metabolic Parameters and Prolactin Levels

by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD

September 1, 2019 No Comments

Drug Development

Olanzapine Plus Samidorphan in Subjects with Schizophrenia and Comorbid Alcohol Use Disorder: Rationale and Design for a Phase II, Double-blind, Randomized Study

by Leslie Citrome, MD, MPH; Stephanie S. O’Malley, PhD; David

May 1, 2019 No Comments

Letters to the Editor

Letter to the Editor: Metabolic Changes in Patients with Schizophrenia Switched from Olanzapine to Asenaprine or Clozapine

By Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD Funding/financial disclosures: The

July 1, 2018 No Comments

Real-world Data on Atypical Antipsychotic Medication Side Effects

by Elisa Cascade; Amir H. Kalali, MD; Sagar Mehra; and

July 27, 2010 No Comments

LATEST DIGITAL EDITION

ARCHIVES

Innovations in Clinical Neuroscience is a subsidiary of Matrix Medical Communications

contact

Links

About

Topics

©2024 Matrix Medical Communications copyright all right reserved.